Clinical Trial Update: Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration [NA]

View source ↗

Summary

This clinical trial update examines serum NGAL levels in hemodialysis patients and their relationship to iron status and intravenous iron administration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Soroka University Medical Center | Conditions: Renal Failure Chronic Requiring Hemodialysis | NA | Status: UNKNOWN